Remdesivir Has ‘Little Or No Effect’ On COVID-19 Mortality: WHO Study

Spread the love

The antiviral drug remdesivir, considered one of the most promising COVID-19 treatments, turns out to do little to prevent deaths from the disease, according to a WHO-backed study.

 

Remdesivir, which was part of the experimental cocktail given to US President Donald Trump when he caught the new coronavirus last month, was one of several reviewed in a large study of more than 11,000 people across 30 countries.

The drug “appeared to have little or no effect on hospitalised COVID-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay,” said the study posted online late Thursday.

The data, which has yet to be peer-reviewed or published in a scientific journal, seems to contradict at least two major US studies that have shown that remdesivir can reduce the duration of hospital stays for COVID-19 patients.

Washington authorised the emergency use of the medicine, made by US pharmaceutical company Gilead Sciences and originally intended as a treatment for Ebola — on May 1, followed by a range of other countries and the European Union.

 

-AFP

 
 



Call Bridget Edokwe Esq on 08060798767 or send your email to ngbarrister@gmail.com

Click to Join Our Facebook Group


Steps To Subscribe To the Court of Appeal Reports Nigeria


Win your Court cases today, Get Affordable Supreme Court Law Reports >> CLICK HERE


BESTSELLER: Get A-Z of contemporary laws of ELECTRONIC EVIDENCE in Nigeria By Alaba Omolaye-Ajileye. To ORDER, sms or call : +2347063666998, +2348159307051 or email jurispublicationseries@gmail.com


Alexander Payne: Get these Law books to aid your practice.

The Reports contain valuable and uncommon locus classicus for Legal research, opinion, and advocacy. Grab your copy now!!! Call 07044444777 or 08181999888. Visit our website: www.alexandernigeria.com/
%d bloggers like this: